3 Biotech Stocks to Buy in December


While biotech stocks in general soared in November after the surprise election of Donald Trump, the SPDR S&P Biotech ETFis still down more than 7% since the start of the year. That suggests there are still plenty of bargains to be found in the sector, so we asked a team of our healthcare contributors to highlight a biotech stock that they think is a great buy.Read on to see why they choose Anika Thearpeutics Brian Feroldi : The vast majority of publicly traded biotech stocks burn through capital each year and are in constant need of cash.



from Biotech News